The role of standard-dose cytarabine in children with acute promyelocytic leukemia: A single-center experience

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 2, 2011, Pages

  Zhang, Li ^a   Zhu, Xiaofan ^a   Chen, Xiaojuan ^a   Chen, Yumei ^a   Zou, Yao ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

acute promyelocytic leukemia; children; cytarabine

Indexed keywords

ARSENIC TRIOXIDE; CYTARABINE; DAUNORUBICIN; HEMOGLOBIN; HOMOHARRINGTONINE; HYDROXYUREA; MERCAPTOPURINE; METHOTREXATE; RETINOIC ACID;

ADOLESCENT; ARTICLE; BONE PAIN; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; DRUG FEVER; DRUG INDUCED HEADACHE; DRY SKIN; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LEUKOCYTOSIS; LOW DRUG DOSE; MALE; MONOTHERAPY; MUCOSAL DRYNESS; MULTIPLE CYCLE TREATMENT; NAUSEA; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RETINOIC ACID SYNDROME; RETROSPECTIVE STUDY; SIDE EFFECT; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT; TREATMENT OUTCOME; TREATMENT RESPONSE;

6-MERCAPTOPURINE; ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CYTARABINE; DAUNORUBICIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; METHOTREXATE; TREATMENT OUTCOME; TRETINOIN;

EID: 79952186948     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181ed3384     Document Type: Article

References (19)

1. Testi AM, Biondi A, Lo Coco F, et al. GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. Blood. 2005;106: 447-453. (Pubitemid 40981236)
2. Ortega JJ, Madero L, Martin G, et al. Treatment with alltrans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: A multicenter study by the PETHEMA Group. J Clin Oncol. 2005;23: 7632-7640. (Pubitemid 46291827)
3. De Botton S, Coiteux V, Chevret S, et al. Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. J Clin Oncol. 2004;22:1404-1012.
4. Mann G, Reinhardt D, Ritter J, et al. Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children. Ann Hematol. 2001;80:417-422. (Pubitemid 32725460)
5. Sanz MA, Lo Coco F, Martin G, et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: A joint study of the PETHEMA and GIMEMA cooperative groups. Blood. 2000; 96:1247-1253. (Pubitemid 30658450)
6. Sanz MA, Martín G, González M, et al. Risk-adapted treatment of acute promyelocytic leukemia with all-transretinoic acid and anthracycline monochemotherapy: A multicenter study by the PETHEMA group. Blood. 2004;103: 1237-1243. (Pubitemid 38168633)
7. Adès L, Chevret S, Raffoux E, et al. Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European acute promyelocytic leukemia group. J Clin Oncol. 2006;24:5703-5710. (Pubitemid 46631312)
8. Avvisati G, Lo Coco F, Diverio D, et al. AIDA (all-trans retinoic acid+idarubicin) in newly diagnosed acute promyelocytic leukemia: A Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study. Blood. 1996;88: 1390-1398. (Pubitemid 26276815)
9. Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the International working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol. 2003;21:4642-4649. (Pubitemid 46594039)
10. Lengfelder E, Haferlach C, Saussele S, et al. High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: Long-term results of the German AMLCG. Leukemia. 2009. [Epub ahead of print].
11. Schlenk RF, Germing U, Hartmann F, et al. High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia. Leukemia. 2005;19:978-983. (Pubitemid 40862008)
12. Tallman MS. What is the role of arsenic in newly diagnosed APL? Best Pract Res Clin Haematol. 2008;21:659-666.
13. Ruggiero A, Ridola V, Puma N, et al. Anthracycline cardiotoxicity in childhood. Pediatr Hematol Oncol. 2008;25: 261-281. (Pubitemid 351874080)
14. Van Dalen EC, Van der Pal HJH, Kok WEM, et al. Clinical heart failure in a cohort of children treated with anthracyclines: A long-term follow up study. Eur J Cancer. 2006;42:3191-3198. (Pubitemid 44872945)
15. Luo XQ, Ke ZY, Huang LB, et al. Improved outcome for Chinese children with acute promyelocytic leukemia: A comparison of two protocols. Pediatr Blood Cancer. 2009;53: 325-328.
16. Powell BL, Moser B, Stock W. Effect of consolidation with arsenic trioxide (As2O3) on event-free survival (EFS) and overall survival (OS) among patients with newly diagnosed acute promyelocytic leukemia (APL): North American intergroup protocoll C9710. J Clin Oncol. 2007;25:1s. [abstract 2].
17. Shen ZX, Shi ZZ, Fang J, et al. All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci U S A. 2004;101:5328-5235.
18. Zhang L, Zhao H, Zhu X, et al. Retrospective analysis of 65 Chinese children with acute promyelocytic leukemia: A single center experience. Pediatr Blood Cancer 2008;51: 210-215. (Pubitemid 351874415)
19. George B, Mathews V, Poonkuzhali B, et al. Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide: A single center experience. Leukemia. 2004;18:1587-1590. (Pubitemid 39386334)